The Delhi High Court's ruling in Array Biopharma v. Deputy Controller emphasizes that objections in patent applications must be substantive and linked to claims rather than mere citations. This decision shapes expectations for applicants and their legal counsel.
Delhi High Court Decision on Patent Applications: Citing Isn’t Applying
The Delhi High Court has delivered a noteworthy judgment in Array Biopharma Inc. v. Deputy Controller of Patents, stressing that when raising objections during patent examinations, parties must substantively connect their claims to the evidence presented rather than relying on mere citations. The ruling underscores the significance of comprehensive reasoning in every stage of the patent application process.
The court's analysis indicated that for objections regarding inventive steps and other critical patentability criteria, the arguments presented must include well-founded factual support. The emphasis on not simply citing past judgments but rather applying relevant principles to the specific situation reflects the court’s commitment to a rigorous examination of patent claims.
This decision may significantly alter the landscape for patent applicants, elucidating the level of scrutiny they can expect during examinations. It provides an essential precedent for legal practitioners, emphasizing the importance of crafting robust applications that thoroughly link objections to provided evidence and applicable law.
Attorneys representing clients in patent matters would do well to engage in detailed analysis and argument formulation, ensuring that their submissions meet the explicit requirements set forth by the court's latest decision.
Citations
- Array Biopharma Inc. v. Deputy Controller of Patents (2026)
